epidermal growth factor receptor การใช้
- Both Herceptin and IMC-C225 are antibodies that block epidermal growth factor receptors.
- AP26113 is a dual inhibitor of ALK and epidermal growth factor receptor.
- Paracrine signalling mediates the response to epidermal growth factor receptor kinase inhibitors.
- It binds to the epidermal growth factor receptor ( EGFR ).
- The drug is a so-called epidermal growth factor receptor antagonist.
- It binds to the epidermal growth factor receptor ( EGFR ) with high affinity.
- He discovered this in studies of the epidermal growth factor receptor ( EGFR ).
- The tumors must not have an epidermal growth factor receptor or anaplastic lymphoma kinase.
- The drug is one of several in development called epidermal growth factor receptor inhibitors.
- Both inhibit epidermal growth factor receptors, which have a role in triggering tumor growth.
- Epidermal growth factor receptor ( EGFR ) inhibitors are medications used in cancer treatment.
- Paracrine activates epidermal growth factor receptor in endothelial cells of the tumor to do this.
- The epidermal growth factor receptor system, as such, has been used as an intermediate example.
- PTPN1 has been shown to interact with BCAR1, epidermal growth factor receptor, Grb2 and IRS1.
- Over-expression or constitutive activation of epidermal growth factor receptor ( EGFR ) can promote tumor processes.
- The epidermal growth factor receptor ( EGFR ) regulates cell proliferation, apoptosis, angiogenesis, and tumor invasion.
- GPR30 binds estrogen, and upon binding estrogen this pathway activates adenylyl cyclase and epidermal growth factor receptor.
- The protein-binding EH domain was first noted in EPS15, a substrate for the epidermal growth factor receptor.
- Drugs of this type include those that target the epidermal growth factor receptors of VEGFR inhibitors ).
- Iressa, a new type of treatment known as Epidermal Growth Factor Receptors, is a tablet taken once daily.
- ตัวอย่างการใช้เพิ่มเติม: 1 2 3